ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

Organ Systems R01 Grants Doing Okay

February 8, 1985

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976